[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Acute Intermittent Porphyria Market Size, Status and Forecast 2020-2026

May 2020 | 90 pages | ID: GE78EAB6B622EN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report focuses on the global Acute Intermittent Porphyria status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Acute Intermittent Porphyria development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
  • Dahaner
  • Roche
  • Bio-Rad Laboratories
  • Siemens
  • ARKRAY
  • Sysmex Corporation
  • ACON Laboratories
  • ...
Market segment by Type, the product can be split into
  • Gonadotropin-Releasing Hormone Analogues
  • Prophylactic Hematin Infusions
Market segment by Application, split into
  • Hospitals & Clinics
  • Research Centers
Market segment by Regions/Countries, this report covers
  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central & South America
The study objectives of this report are:
  • To analyze global Acute Intermittent Porphyria status, future forecast, growth opportunity, key market and key players.
  • To present the Acute Intermittent Porphyria development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
  • To strategically profile the key players and comprehensively analyze their development plan and strategies.
  • To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Acute Intermittent Porphyria are as follows:
  • History Year: 2015-2019
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Acute Intermittent Porphyria Revenue
1.4 Market Analysis by Type
  1.4.1 Global Acute Intermittent Porphyria Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Gonadotropin-Releasing Hormone Analogues
  1.4.3 Prophylactic Hematin Infusions
1.5 Market by Application
  1.5.1 Global Acute Intermittent Porphyria Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals & Clinics
  1.5.3 Research Centers
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Acute Intermittent Porphyria Market Perspective (2015-2026)
2.2 Acute Intermittent Porphyria Growth Trends by Regions
  2.2.1 Acute Intermittent Porphyria Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Acute Intermittent Porphyria Historic Market Share by Regions (2015-2020)
  2.2.3 Acute Intermittent Porphyria Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Acute Intermittent Porphyria Market Growth Strategy
  2.3.6 Primary Interviews with Key Acute Intermittent Porphyria Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Acute Intermittent Porphyria Players by Market Size
  3.1.1 Global Top Acute Intermittent Porphyria Players by Revenue (2015-2020)
  3.1.2 Global Acute Intermittent Porphyria Revenue Market Share by Players (2015-2020)
  3.1.3 Global Acute Intermittent Porphyria Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Acute Intermittent Porphyria Market Concentration Ratio
  3.2.1 Global Acute Intermittent Porphyria Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Acute Intermittent Porphyria Revenue in 2019
3.3 Acute Intermittent Porphyria Key Players Head office and Area Served
3.4 Key Players Acute Intermittent Porphyria Product Solution and Service
3.5 Date of Enter into Acute Intermittent Porphyria Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Acute Intermittent Porphyria Historic Market Size by Type (2015-2020)
4.2 Global Acute Intermittent Porphyria Forecasted Market Size by Type (2021-2026)

5 ACUTE INTERMITTENT PORPHYRIA BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Acute Intermittent Porphyria Market Size by Application (2015-2020)
5.2 Global Acute Intermittent Porphyria Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Acute Intermittent Porphyria Market Size (2015-2020)
6.2 Acute Intermittent Porphyria Key Players in North America (2019-2020)
6.3 North America Acute Intermittent Porphyria Market Size by Type (2015-2020)
6.4 North America Acute Intermittent Porphyria Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Acute Intermittent Porphyria Market Size (2015-2020)
7.2 Acute Intermittent Porphyria Key Players in Europe (2019-2020)
7.3 Europe Acute Intermittent Porphyria Market Size by Type (2015-2020)
7.4 Europe Acute Intermittent Porphyria Market Size by Application (2015-2020)

8 CHINA

8.1 China Acute Intermittent Porphyria Market Size (2015-2020)
8.2 Acute Intermittent Porphyria Key Players in China (2019-2020)
8.3 China Acute Intermittent Porphyria Market Size by Type (2015-2020)
8.4 China Acute Intermittent Porphyria Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Acute Intermittent Porphyria Market Size (2015-2020)
9.2 Acute Intermittent Porphyria Key Players in Japan (2019-2020)
9.3 Japan Acute Intermittent Porphyria Market Size by Type (2015-2020)
9.4 Japan Acute Intermittent Porphyria Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Acute Intermittent Porphyria Market Size (2015-2020)
10.2 Acute Intermittent Porphyria Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Acute Intermittent Porphyria Market Size by Type (2015-2020)
10.4 Southeast Asia Acute Intermittent Porphyria Market Size by Application (2015-2020)

11 INDIA

11.1 India Acute Intermittent Porphyria Market Size (2015-2020)
11.2 Acute Intermittent Porphyria Key Players in India (2019-2020)
11.3 India Acute Intermittent Porphyria Market Size by Type (2015-2020)
11.4 India Acute Intermittent Porphyria Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Acute Intermittent Porphyria Market Size (2015-2020)
12.2 Acute Intermittent Porphyria Key Players in Central & South America (2019-2020)
12.3 Central & South America Acute Intermittent Porphyria Market Size by Type (2015-2020)
12.4 Central & South America Acute Intermittent Porphyria Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Dahaner
  13.1.1 Dahaner Company Details
  13.1.2 Dahaner Business Overview and Its Total Revenue
  13.1.3 Dahaner Acute Intermittent Porphyria Introduction
  13.1.4 Dahaner Revenue in Acute Intermittent Porphyria Business (2015-2020))
  13.1.5 Dahaner Recent Development
13.2 Roche
  13.2.1 Roche Company Details
  13.2.2 Roche Business Overview and Its Total Revenue
  13.2.3 Roche Acute Intermittent Porphyria Introduction
  13.2.4 Roche Revenue in Acute Intermittent Porphyria Business (2015-2020)
  13.2.5 Roche Recent Development
13.3 Bio-Rad Laboratories
  13.3.1 Bio-Rad Laboratories Company Details
  13.3.2 Bio-Rad Laboratories Business Overview and Its Total Revenue
  13.3.3 Bio-Rad Laboratories Acute Intermittent Porphyria Introduction
  13.3.4 Bio-Rad Laboratories Revenue in Acute Intermittent Porphyria Business (2015-2020)
  13.3.5 Bio-Rad Laboratories Recent Development
13.4 Siemens
  13.4.1 Siemens Company Details
  13.4.2 Siemens Business Overview and Its Total Revenue
  13.4.3 Siemens Acute Intermittent Porphyria Introduction
  13.4.4 Siemens Revenue in Acute Intermittent Porphyria Business (2015-2020)
  13.4.5 Siemens Recent Development
13.5 ARKRAY
  13.5.1 ARKRAY Company Details
  13.5.2 ARKRAY Business Overview and Its Total Revenue
  13.5.3 ARKRAY Acute Intermittent Porphyria Introduction
  13.5.4 ARKRAY Revenue in Acute Intermittent Porphyria Business (2015-2020)
  13.5.5 ARKRAY Recent Development
13.6 Sysmex Corporation
  13.6.1 Sysmex Corporation Company Details
  13.6.2 Sysmex Corporation Business Overview and Its Total Revenue
  13.6.3 Sysmex Corporation Acute Intermittent Porphyria Introduction
  13.6.4 Sysmex Corporation Revenue in Acute Intermittent Porphyria Business (2015-2020)
  13.6.5 Sysmex Corporation Recent Development
13.7 ACON Laboratories
  13.7.1 ACON Laboratories Company Details
  13.7.2 ACON Laboratories Business Overview and Its Total Revenue
  13.7.3 ACON Laboratories Acute Intermittent Porphyria Introduction
  13.7.4 ACON Laboratories Revenue in Acute Intermittent Porphyria Business (2015-2020)
  13.7.5 ACON Laboratories Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES

Table 1. Acute Intermittent Porphyria Key Market Segments
Table 2. Key Players Covered: Ranking by Acute Intermittent Porphyria Revenue
Table 3. Ranking of Global Top Acute Intermittent Porphyria Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Acute Intermittent Porphyria Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Gonadotropin-Releasing Hormone Analogues
Table 6. Key Players of Prophylactic Hematin Infusions
Table 7. Global Acute Intermittent Porphyria Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Acute Intermittent Porphyria Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Acute Intermittent Porphyria Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Acute Intermittent Porphyria Market Share by Regions (2015-2020)
Table 11. Global Acute Intermittent Porphyria Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Acute Intermittent Porphyria Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Acute Intermittent Porphyria Market Growth Strategy
Table 17. Main Points Interviewed from Key Acute Intermittent Porphyria Players
Table 18. Global Acute Intermittent Porphyria Revenue by Players (2015-2020) (Million US$)
Table 19. Global Acute Intermittent Porphyria Market Share by Players (2015-2020)
Table 20. Global Top Acute Intermittent Porphyria Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Intermittent Porphyria as of 2019)
Table 21. Global Acute Intermittent Porphyria by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Acute Intermittent Porphyria Product Solution and Service
Table 24. Date of Enter into Acute Intermittent Porphyria Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Acute Intermittent Porphyria Market Size by Type (2015-2020) (Million US$)
Table 27. Global Acute Intermittent Porphyria Market Size Share by Type (2015-2020)
Table 28. Global Acute Intermittent Porphyria Revenue Market Share by Type (2021-2026)
Table 29. Global Acute Intermittent Porphyria Market Size Share by Application (2015-2020)
Table 30. Global Acute Intermittent Porphyria Market Size by Application (2015-2020) (Million US$)
Table 31. Global Acute Intermittent Porphyria Market Size Share by Application (2021-2026)
Table 32. North America Key Players Acute Intermittent Porphyria Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Acute Intermittent Porphyria Market Share (2019-2020)
Table 34. North America Acute Intermittent Porphyria Market Size by Type (2015-2020) (Million US$)
Table 35. North America Acute Intermittent Porphyria Market Share by Type (2015-2020)
Table 36. North America Acute Intermittent Porphyria Market Size by Application (2015-2020) (Million US$)
Table 37. North America Acute Intermittent Porphyria Market Share by Application (2015-2020)
Table 38. Europe Key Players Acute Intermittent Porphyria Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Acute Intermittent Porphyria Market Share (2019-2020)
Table 40. Europe Acute Intermittent Porphyria Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Acute Intermittent Porphyria Market Share by Type (2015-2020)
Table 42. Europe Acute Intermittent Porphyria Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Acute Intermittent Porphyria Market Share by Application (2015-2020)
Table 44. China Key Players Acute Intermittent Porphyria Revenue (2019-2020) (Million US$)
Table 45. China Key Players Acute Intermittent Porphyria Market Share (2019-2020)
Table 46. China Acute Intermittent Porphyria Market Size by Type (2015-2020) (Million US$)
Table 47. China Acute Intermittent Porphyria Market Share by Type (2015-2020)
Table 48. China Acute Intermittent Porphyria Market Size by Application (2015-2020) (Million US$)
Table 49. China Acute Intermittent Porphyria Market Share by Application (2015-2020)
Table 50. Japan Key Players Acute Intermittent Porphyria Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Acute Intermittent Porphyria Market Share (2019-2020)
Table 52. Japan Acute Intermittent Porphyria Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Acute Intermittent Porphyria Market Share by Type (2015-2020)
Table 54. Japan Acute Intermittent Porphyria Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Acute Intermittent Porphyria Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Acute Intermittent Porphyria Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Acute Intermittent Porphyria Market Share (2019-2020)
Table 58. Southeast Asia Acute Intermittent Porphyria Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Acute Intermittent Porphyria Market Share by Type (2015-2020)
Table 60. Southeast Asia Acute Intermittent Porphyria Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Acute Intermittent Porphyria Market Share by Application (2015-2020)
Table 62. India Key Players Acute Intermittent Porphyria Revenue (2019-2020) (Million US$)
Table 63. India Key Players Acute Intermittent Porphyria Market Share (2019-2020)
Table 64. India Acute Intermittent Porphyria Market Size by Type (2015-2020) (Million US$)
Table 65. India Acute Intermittent Porphyria Market Share by Type (2015-2020)
Table 66. India Acute Intermittent Porphyria Market Size by Application (2015-2020) (Million US$)
Table 67. India Acute Intermittent Porphyria Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Acute Intermittent Porphyria Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Acute Intermittent Porphyria Market Share (2019-2020)
Table 70. Central & South America Acute Intermittent Porphyria Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Acute Intermittent Porphyria Market Share by Type (2015-2020)
Table 72. Central & South America Acute Intermittent Porphyria Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Acute Intermittent Porphyria Market Share by Application (2015-2020)
Table 74. Dahaner Company Details
Table 75. Dahaner Business Overview
Table 76. Dahaner Product
Table 77. Dahaner Revenue in Acute Intermittent Porphyria Business (2015-2020) (Million US$)
Table 78. Dahaner Recent Development
Table 79. Roche Company Details
Table 80. Roche Business Overview
Table 81. Roche Product
Table 82. Roche Revenue in Acute Intermittent Porphyria Business (2015-2020) (Million US$)
Table 83. Roche Recent Development
Table 84. Bio-Rad Laboratories Company Details
Table 85. Bio-Rad Laboratories Business Overview
Table 86. Bio-Rad Laboratories Product
Table 87. Bio-Rad Laboratories Revenue in Acute Intermittent Porphyria Business (2015-2020) (Million US$)
Table 88. Bio-Rad Laboratories Recent Development
Table 89. Siemens Company Details
Table 90. Siemens Business Overview
Table 91. Siemens Product
Table 92. Siemens Revenue in Acute Intermittent Porphyria Business (2015-2020) (Million US$)
Table 93. Siemens Recent Development
Table 94. ARKRAY Company Details
Table 95. ARKRAY Business Overview
Table 96. ARKRAY Product
Table 97. ARKRAY Revenue in Acute Intermittent Porphyria Business (2015-2020) (Million US$)
Table 98. ARKRAY Recent Development
Table 99. Sysmex Corporation Company Details
Table 100. Sysmex Corporation Business Overview
Table 101. Sysmex Corporation Product
Table 102. Sysmex Corporation Revenue in Acute Intermittent Porphyria Business (2015-2020) (Million US$)
Table 103. Sysmex Corporation Recent Development
Table 104. ACON Laboratories Company Details
Table 105. ACON Laboratories Business Overview
Table 106. ACON Laboratories Product
Table 107. ACON Laboratories Revenue in Acute Intermittent Porphyria Business (2015-2020) (Million US$)
Table 108. ACON Laboratories Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Global Acute Intermittent Porphyria Market Share by Type: 2020 VS 2026
Figure 2. Gonadotropin-Releasing Hormone Analogues Features
Figure 3. Prophylactic Hematin Infusions Features
Figure 4. Global Acute Intermittent Porphyria Market Share by Application: 2020 VS 2026
Figure 5. Hospitals & Clinics Case Studies
Figure 6. Research Centers Case Studies
Figure 7. Acute Intermittent Porphyria Report Years Considered
Figure 8. Global Acute Intermittent Porphyria Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Acute Intermittent Porphyria Market Share by Regions: 2020 VS 2026
Figure 10. Global Acute Intermittent Porphyria Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Acute Intermittent Porphyria Market Share by Players in 2019
Figure 13. Global Top Acute Intermittent Porphyria Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Intermittent Porphyria as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Acute Intermittent Porphyria Revenue in 2019
Figure 15. North America Acute Intermittent Porphyria Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Acute Intermittent Porphyria Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Acute Intermittent Porphyria Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Acute Intermittent Porphyria Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Acute Intermittent Porphyria Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Acute Intermittent Porphyria Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Acute Intermittent Porphyria Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Dahaner Total Revenue (US$ Million): 2019 Compared with 2018
Figure 23. Dahaner Revenue Growth Rate in Acute Intermittent Porphyria Business (2015-2020)
Figure 24. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Roche Revenue Growth Rate in Acute Intermittent Porphyria Business (2015-2020)
Figure 26. Bio-Rad Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Bio-Rad Laboratories Revenue Growth Rate in Acute Intermittent Porphyria Business (2015-2020)
Figure 28. Siemens Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Siemens Revenue Growth Rate in Acute Intermittent Porphyria Business (2015-2020)
Figure 30. ARKRAY Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. ARKRAY Revenue Growth Rate in Acute Intermittent Porphyria Business (2015-2020)
Figure 32. Sysmex Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Sysmex Corporation Revenue Growth Rate in Acute Intermittent Porphyria Business (2015-2020)
Figure 34. ACON Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. ACON Laboratories Revenue Growth Rate in Acute Intermittent Porphyria Business (2015-2020)
Figure 36. Bottom-up and Top-down Approaches for This Report
Figure 37. Data Triangulation
Figure 38. Key Executives Interviewed


More Publications